Franck A. Atienzar

1.2k citations

12 papers · 913 indexed · 1 hit paper · h-index 11

Molecular Biology
Pharmacology top 2%
Hepatology top 5%
Biomedical Engineering
Computational Theory and Mathematics top 5%

Co-authors: Helga H.J. Gerets Stéphane Dhalluin Karen Tilmant B. O. Depelchin Hugues Chanteux Brigitte Gerin Étienne Hanon André Nogueira da Costa
Topics: Drug-Induced Hepatotoxicity and Protection (5 papers)Computational Drug Discovery Methods (3 papers)3D Printing in Biomedical Research (3 papers)
Cited by: Pharmacology Hepatology Small Animals
Journals: Toxicology and Applied Pharmacology BMC Genomics Environmental Toxicology and Chemistry
Partner nations: Belgium France United States

In The Last Decade

Franck A. Atienzar

12 papers receiving 892 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins

2012 551 citations Helga H.J. Gerets, Karen Tilmant et al. Cell Biology and Toxicology profile →

Peers

Countries citing papers authored by Franck A. Atienzar

Since Specialization

Citations

This map shows the geographic impact of Franck A. Atienzar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franck A. Atienzar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franck A. Atienzar more than expected).

Fields of papers citing papers by Franck A. Atienzar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franck A. Atienzar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franck A. Atienzar. The network helps show where Franck A. Atienzar may publish in the future.

Co-authorship network of co-authors of Franck A. Atienzar

This figure shows the co-authorship network connecting the top 25 collaborators of Franck A. Atienzar. A scholar is included among the top collaborators of Franck A. Atienzar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Franck A. Atienzar. Franck A. Atienzar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	In vitro screening of cell bioenergetics to assess mitochondrial dysfunction in drug development 2018 ·Toxicology in Vitro ·Karen Tilmant,Helga H.J. Gerets,(unknown),Étienne Hanon,(unknown),Franck A. Atienzar	10
2	Current trends in in silico, in vitro toxicology, and safety biomarkers in early drug development 2017 ·Drug and Chemical Toxicology ·(unknown),André Nogueira da Costa,Franck A. Atienzar	29
3	Key Challenges and Opportunities Associated with the Use of In Vitro Models to Detect Human DILI: Integrated Risk Assessment and Mitigation Plans 2016 ·BioMed Research International ·Franck A. Atienzar,Eric A.G. Blomme,Minjun Chen,Philip Hewitt,J. Gerry Kenna,Gilles Labbe,Frederic Moulin,François Pognan,Adrian Roth,Laura Suter‐Dick,Okechukwu Ukairo,Richard Weaver,Yvonne Will,Donna M. Dambach	44
4	Predictivity of dog co-culture model, primary human hepatocytes and HepG2 cells for the detection of hepatotoxic drugs in humans 2013 ·Toxicology and Applied Pharmacology ·Franck A. Atienzar,Eric Novik,Helga H.J. Gerets,(unknown),Claude Delatour,Á. de Pablo Cárdenas,J. S. Macdonald,Martin L. Yarmush,Stéphane Dhalluin	44
5	Evaluation of Impedance-Based Label-Free Technology as a Tool for Pharmacology and Toxicology Investigations 2013 ·Biosensors ·Franck A. Atienzar,Helga H.J. Gerets,Karen Tilmant,(unknown),Stéphane Dhalluin	38
6	Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxinsbreakdown → 2012 ·Cell Biology and Toxicology ·Helga H.J. Gerets,Karen Tilmant,Brigitte Gerin,Hugues Chanteux,B. O. Depelchin,Stéphane Dhalluin,Franck A. Atienzar	551
7	Multiplexing Cell Viability Assays 2011 ·Methods in molecular biology ·Helga H.J. Gerets,Stéphane Dhalluin,Franck A. Atienzar	13
8	Transcriptomic effects of di-(2-ethylhexyl)-phthalate in Syrian hamster embryo cells: an important role of early cytoskeleton disturbances in carcinogenesis? 2011 ·BMC Genomics ·Yann Landkocz,Pascal Poupin,Franck A. Atienzar,Paule Vasseur	16
9	The Use of Real-Time Cell Analyzer Technology in Drug Discovery: Defining Optimal Cell Culture Conditions and Assay Reproducibility with Different Adherent Cellular Models 2011 ·SLAS DISCOVERY ·Franck A. Atienzar,Karen Tilmant,Helga H.J. Gerets,(unknown),(unknown),Étienne Hanon,(unknown),Stéphane Dhalluin	82
10	Phenyl‐oxazoles, a New Family of Inverse Agonists at the H₃ Histamine Receptor 2009 ·ChemMedChem ·(unknown),Franck A. Atienzar,Sylvain Célanire,B. Christophe,(unknown),(unknown),Marie‐Laure Delporte,(unknown),Michel Gillard,Bénédicte Lallemand,Yves Lamberty,(unknown),(unknown),(unknown),(unknown),Laurent Provins	13
11	Selection of cytotoxicity markers for the screening of new chemical entities in a pharmaceutical context: A preliminary study using a multiplexing approach 2008 ·Toxicology in Vitro ·Helga H.J. Gerets,Étienne Hanon,(unknown),Stéphane Dhalluin,(unknown),(unknown),Franck A. Atienzar	52
12	QUALITATIVE ASSESSMENT OF GENOTOXICITY USING RANDOM AMPLIFIED POLYMORPHIC DNA: COMPARISON OF GENOMIC TEMPLATE STABILITY WITH KEY FITNESS PARAMETERS IN DAPHNIA MAGNA EXPOSED TO BENZO[a]PYRENE 1999 ·Environmental Toxicology and Chemistry ·Franck A. Atienzar,Mercedes Conradi,Andrew J. Evenden,Awadhesh N. Jha,Michael H. Depledge	21

About Franck A. Atienzar

Franck A. Atienzar is a scholar working on Pharmacology, Biophysics and Small Animals, having authored 12 papers that have together received 913 indexed citations. Recurring topics across this work include Drug-Induced Hepatotoxicity and Protection (5 papers), Computational Drug Discovery Methods (3 papers) and 3D Printing in Biomedical Research (3 papers). The work is most often cited by research in Pharmacology (243 citations), Hepatology (208 citations) and Small Animals (48 citations). Franck A. Atienzar has collaborated with scholars based in Belgium, France and United States. Frequent co-authors include Helga H.J. Gerets, Stéphane Dhalluin, Karen Tilmant, B. O. Depelchin, Hugues Chanteux, Brigitte Gerin, Étienne Hanon, André Nogueira da Costa, Á. de Pablo Cárdenas and Claude Delatour. Their work appears in journals such as Toxicology and Applied Pharmacology, BMC Genomics and Environmental Toxicology and Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact